Correlation Between Arcutis Biotherapeutics and Immunoprecise Antibodies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arcutis Biotherapeutics and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcutis Biotherapeutics and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcutis Biotherapeutics and Immunoprecise Antibodies, you can compare the effects of market volatilities on Arcutis Biotherapeutics and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcutis Biotherapeutics with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcutis Biotherapeutics and Immunoprecise Antibodies.

Diversification Opportunities for Arcutis Biotherapeutics and Immunoprecise Antibodies

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Arcutis and Immunoprecise is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Arcutis Biotherapeutics and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and Arcutis Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcutis Biotherapeutics are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of Arcutis Biotherapeutics i.e., Arcutis Biotherapeutics and Immunoprecise Antibodies go up and down completely randomly.

Pair Corralation between Arcutis Biotherapeutics and Immunoprecise Antibodies

Given the investment horizon of 90 days Arcutis Biotherapeutics is expected to generate 0.84 times more return on investment than Immunoprecise Antibodies. However, Arcutis Biotherapeutics is 1.2 times less risky than Immunoprecise Antibodies. It trades about 0.0 of its potential returns per unit of risk. Immunoprecise Antibodies is currently generating about -0.36 per unit of risk. If you would invest  2,088  in Arcutis Biotherapeutics on March 29, 2022 and sell it today you would lose (27.00)  from holding Arcutis Biotherapeutics or give up 1.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Arcutis Biotherapeutics  vs.  Immunoprecise Antibodies

 Performance (%) 
      Timeline 
Arcutis Biotherapeutics 
Arcutis Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Arcutis Biotherapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Arcutis Biotherapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Arcutis Price Channel

Immunoprecise Antibodies 
Immunoprecise Performance
0 of 100
Over the last 90 days Immunoprecise Antibodies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Immunoprecise Antibodies is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Structure and Payout Changes

Last Split Factor
1:5
Dividend Date
2020-11-23
Last Split Date
2020-11-23

Immunoprecise Price Channel

Arcutis Biotherapeutics and Immunoprecise Antibodies Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Arcutis Biotherapeutics and Immunoprecise Antibodies

The main advantage of trading using opposite Arcutis Biotherapeutics and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcutis Biotherapeutics position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.

Arcutis Biotherapeutics

Pair trading matchups for Arcutis Biotherapeutics

Verizon Communications vs. Arcutis Biotherapeutics
Northrop Grumman vs. Arcutis Biotherapeutics
Cincinnati Financial vs. Arcutis Biotherapeutics
Conagra Brands vs. Arcutis Biotherapeutics
Chevron Corp vs. Arcutis Biotherapeutics
Merck vs. Arcutis Biotherapeutics
Micron Technology vs. Arcutis Biotherapeutics
Home Depot vs. Arcutis Biotherapeutics
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Arcutis Biotherapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Arcutis Biotherapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Arcutis Biotherapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Arcutis Biotherapeutics.
The idea behind Arcutis Biotherapeutics and Immunoprecise Antibodies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Immunoprecise Antibodies

Pair trading matchups for Immunoprecise Antibodies

Cincinnati Financial vs. Immunoprecise Antibodies
Conagra Brands vs. Immunoprecise Antibodies
Macroaxis vs. Immunoprecise Antibodies
Micron Technology vs. Immunoprecise Antibodies
Merck vs. Immunoprecise Antibodies
Verizon Communications vs. Immunoprecise Antibodies
Northrop Grumman vs. Immunoprecise Antibodies
Teucrium Corn vs. Immunoprecise Antibodies
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Immunoprecise Antibodies as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Immunoprecise Antibodies' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Immunoprecise Antibodies' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Immunoprecise Antibodies.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go